Diagnostic value of antibodies against a modified citrullinated vimentin, cyclic citrullinated peptide and IgM rheumatoid factor in early rheumatoid arthritis

被引：0
|
作者：
Novikov, A. A. [1 ]
Alexandrova, E. N. [1 ]
Karateev, D. E. [1 ]
Demidova, N. V. [1 ]
Cherkasova, M. V. [1 ]
Denisov, L. N. [1 ]
Nasonov, E. L. [1 ]
机构：
[1] State Inst Rheumatol, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：333 / 333
页数：1
相关论文
共 50 条
  • [31] Antibodies against cyclic citrullinated peptide and against modified citrullinated vimentin in patients with ankylosing spondylitis (AS)
    Yatsyshyn, R.
    Yatsyshyn, N.
    Neyko, Y.
    [J]. ALLERGY, 2010, 65 : 466 - 466
  • [32] EVALUATION OF CITRULLINATED ANTI-VIMENTIN ANTIBODIES, ANTI-CITRULLINATED CYCLIC PEPTIDE ANTIBODIES IN ECUADORIAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Zurita-Salinas, Camilo
    Aguilera-Leon, Cristina
    Mestanza-Peralta, Marilu
    Zurita-Mestanza, Alejandro
    Meneses, Simon
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S55 - S55
  • [33] Antibodies against mutated citrullinated vimentin (MCV) are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptide (CCP)
    Innala, L.
    Kokkonen, H.
    Eriksson, C.
    Jidell, E.
    Berglin, E.
    Rantapaeae-Dahlqvist, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 336 - 336
  • [34] ANTIBODIES OF IGG, IGA AND IGM ISOTYPES AGAINST CYCLIC CITRULLINATED PEPTIDE PRECEDE THE DEVELOPMENT OF RHEUMATOID ARTHRITIS
    Kokkonen, Heidi
    Mullazehi, Mohammed
    Ronnelid, Johan
    Rantapaa-Dahlqvist, Solbritt
    [J]. RHEUMATOLOGY, 2011, 50 : ii9 - ii9
  • [35] THE DIAGNOSTIC AND CLINICAL VALUE OF ANTI-MUTATED CITRULLINATED VIMENTIN ANTIBODIES IN RHEUMATOID ARTHRITIS
    Chen, Q. P.
    Chen, Y.
    Peng, J.
    Chen, Q.
    Xiong, Y. M.
    Liu, D.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A126 - A126
  • [36] Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis
    Matsui, Toshihiro
    Shimada, Kota
    Ozawa, Naoko
    Hayakawa, Hiromi
    Hagiwara, Futoshi
    Nakayama, Hisanori
    Sugii, Shoji
    Ozawa, Yoshinori
    Tohma, Shigeto
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (12) : 2390 - 2397
  • [37] Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis
    Jansen, ALMA
    van der Horst-Bruinsma, IE
    van Schaardenburg, D
    van de Stadt, RJ
    de Koning, MHMT
    Dijkmans, BAC
    [J]. JOURNAL OF RHEUMATOLOGY, 2002, 29 (10) : 2074 - 2076
  • [38] Diagnostic performances of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis
    Sghiri, Rim
    Bouagina, Elyes
    Zaglaoui, Hela
    Mestiri, Hajer
    Harzallah, Latifa
    Harrabi, Imed
    Ghannouchi, Mehdi
    Mokhtar, Faycel
    Ghedira, Ibtissem
    [J]. RHEUMATOLOGY INTERNATIONAL, 2007, 27 (12) : 1125 - 1130
  • [39] Diagnostic performances of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis
    Rim Sghiri
    Elyes Bouagina
    Hela Zaglaoui
    Hajer Mestiri
    Latifa Harzallah
    Imed Harrabi
    Mehdi Ghannouchi
    Faycel Mokhtar
    Ibtissem Ghedira
    [J]. Rheumatology International, 2007, 27 : 1125 - 1130
  • [40] Association of Anti-Modified Citrullinated Vimentin with Subclinical Atherosclerosis in Early Rheumatoid Arthritis Compared with Anti-Cyclic Citrullinated Peptide
    El-Barbary, Amal M.
    Kassem, Elham M.
    El-Sergany, Mervat A. S.
    Essa, Salwa A-M.
    Eltomey, Mohamed A.
    [J]. JOURNAL OF RHEUMATOLOGY, 2011, 38 (05) : 828 - 834
12345